Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients
Wei Wang,
Chen Dai,
Peng Zhu,
Mi Wu,
Haoquan Zhang,
Qing Wei,
Ting Zhou,
Xiaosheng Tan,
Ying Jiang,
Xue Cheng,
Zhihui Liang,
Xiongwen Wu,
Zhishui Chen () and
Xiufang Weng ()
Additional contact information
Wei Wang: Huazhong University of Science and Technology
Chen Dai: Chinese Academy of Medical Sciences; Organ Transplantation Clinical Medical Research Center of Hubei Province
Peng Zhu: Huazhong University of Science and Technology
Mi Wu: Huazhong University of Science and Technology
Haoquan Zhang: Huazhong University of Science and Technology
Qing Wei: Huazhong University of Science and Technology
Ting Zhou: Huazhong University of Science and Technology
Xiaosheng Tan: Chinese Academy of Medical Sciences; Organ Transplantation Clinical Medical Research Center of Hubei Province
Ying Jiang: Huazhong University of Science and Technology
Xue Cheng: Huazhong University of Science and Technology
Zhihui Liang: Huazhong University of Science and Technology
Xiongwen Wu: Huazhong University of Science and Technology
Zhishui Chen: Chinese Academy of Medical Sciences; Organ Transplantation Clinical Medical Research Center of Hubei Province
Xiufang Weng: Huazhong University of Science and Technology
Nature Communications, 2025, vol. 16, issue 1, 1-16
Abstract:
Abstract Mucosal-associated invariant T (MAIT) cells exert multifaceted effects such as anti-microbial activity, tissue repair, and pro-fibrotic effects across various disease settings. Nonetheless, their role in liver injury and hemostasis remains debated. Here, we report a significant depletion and functional dysregulation of MAIT cells, which is associated with disease severity and accumulated bile acids in HBV-infected patients with varying degree of liver injury. Liver transplantation facilitates a gradual recovery of recipient-originated MAIT cells. Transcriptome analysis reveals enhanced MAIT cell activation, while TCR mining demonstrates clonotype overlap between circulating and hepatic MAIT cells during significant liver injury. TCR-activated MAIT cells from transplant recipients display higher protective capacity but reduced pathological potential than those from liver failure patients. Compromised recovery of MAIT cells is linked to post-transplantation complications, whereas prompt recovery predicates favorable clinical outcome. These findings underscore the intricate interplay between MAIT cells and the hepatic environment, highlighting MAIT cells as potential therapeutic targets and sensitive predictors for clinical outcome in individuals experiencing liver failure and post liver transplantation.
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-025-59308-x Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59308-x
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-025-59308-x
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().